The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.
about
Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trialThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmThe International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelinesThe International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of GuidelinesIs anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis.Comparison the effectiveness of aripiprazole and risperidone for the treatment of acute bipolar mania.Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.Korean Medication Algorithm Project for Bipolar Disorder: third revision.Management of Bipolar II DisorderKorean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Clinical profile and outcome of bipolar disorder patients receiving electroconvulsive therapy: a study from north India.Medication use, service utilization, and medical costs associated with new episodes of bipolar disorder: evidence from a retrospective claims databasePrepubertal bipolar disorder: available pharmacological treatment options.Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.The safety and tolerability of atypical antipsychotics in bipolar disorder.A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder.Issues in the management of acute agitation: how much current guidelines consider safety?Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care servicePharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials.Frequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature.Is lithium in a class of its own? A brief profile of its clinical use.Prevention of homicidal behaviour in men with psychiatric disorders.How close is evidence to truth in evidence-based treatment of mental disorders?Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis.Do current national and international guidelines have specific recommendations for older adults with bipolar disorder? A brief report.A Case Report of Mania and Psychosis Five Months after Traumatic Brain Injury Successfully Treated Using Olanzapine.The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features.The management of acute mania.Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.Revised Korean medication algorithm for bipolar disorder.WFSBP Treatment Guidelines and the problem of evidence grading.Occurence of ultra-rapid cycling during electroconvulsive therapy in bipolar depression.Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study.New directions in the rational design of electrical and magnetic seizure therapies: individualized Low Amplitude Seizure Therapy (iLAST) and Magnetic Seizure Therapy (MST).
P2860
Q24656287-13727328-19C8-40F8-AE07-CB6CB9EB1572Q28066714-EF865C7D-5D7F-48A7-B93A-F3687E943023Q28069743-61524F9C-7226-4C94-A4C2-3EA1E6D5929CQ28076486-E06D1F76-8F1B-49E6-89F4-4D950B810A97Q33518859-B25F8202-B886-41F5-97C1-25B96C42D2DFQ33788485-D3EA5764-C7D9-4F28-BCA4-52FBEACF8704Q34529810-F0FF3B85-2833-499D-9123-9AF578C09985Q34547920-089061F6-BD9E-4FA9-B62F-538219244D2AQ34550618-C9F5AF5B-D755-480D-A330-698B91CC6BF2Q34578945-FF0F1668-D106-41DD-B14A-28CE7CDBFD7CQ34589017-8F6D6806-AD41-470D-8EE0-388583F18F02Q34606256-F3DC28C3-5B64-411A-BD9C-2C57B70042F3Q35142737-1AB7FAC8-6351-49DB-970F-D362F148E159Q35365581-09ABAFC5-CDD6-4749-AA1F-764598465A8BQ35822006-148A531F-4288-4B13-9985-6FD06710EBE9Q35862776-CE5FE0BA-50A4-42E4-9498-9E7055A52626Q35919586-3B6E9D77-0576-440C-ABF6-1E774D8EBAFDQ36060007-CECAA061-178E-4174-951A-ED39B630942AQ36150677-0590F06F-C6E4-413D-A8E2-14ACFFDE7E86Q36162402-F328D690-D7F6-4716-9369-FF74DCCF1EF2Q36235502-B007E368-0967-409F-A203-9243A4FC0F45Q36560064-8EBCCA17-FDB0-41AB-812F-CC3271E03571Q36821982-270BB030-EA0A-4A77-9221-C29CC8C7D96AQ37115466-1CBA9787-AF7B-41A8-AFA2-1A5ED2CF1B00Q37219379-70A62B53-D97A-42B5-B7E1-644D64BE9B21Q37648736-EDB2362A-3FB4-4FEC-A5EB-54FFE0FA1BF5Q37650273-B4757F4C-C256-4A7A-A060-C851A2E5A9D4Q38443059-07E0AC2B-D04E-41A2-8136-CA1F0C14A501Q38480790-2B407020-879E-4310-8219-6842A2BC90ABQ38536939-064289D1-C7EC-44E7-91C2-892EA18A4F89Q38904156-5B1F9B60-A0EA-4CB0-B1AF-C106455C2C40Q41038446-CFC2CF87-C3CD-401C-B8DA-CE83346B7C84Q41638870-2C032601-7FE4-49CD-B814-EA0413B8772AQ43059254-B2EA8570-9A1B-4D53-98AB-782E97116361Q43119910-6FD8CCB7-A096-45B6-885B-4F36A80C1AECQ45336273-F7CAD21A-696C-4ECE-8019-9CC0640D2F29Q45773049-E2144853-D499-4E07-8FD4-B9E5AFB30B0EQ46145090-A3C26034-76BD-400C-91E1-65504575AB9DQ46202394-B9D56A6F-F829-4BC3-B52B-D78C62A1A70BQ47347804-6FBBAE2F-3BD1-4FF6-B896-B4768E227EB2
P2860
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The World Federation of Societ ...... , Part II: Treatment of Mania.
@ast
The World Federation of Societ ...... , Part II: Treatment of Mania.
@en
The World Federation of Societ ...... , Part II: Treatment of Mania.
@nl
type
label
The World Federation of Societ ...... , Part II: Treatment of Mania.
@ast
The World Federation of Societ ...... , Part II: Treatment of Mania.
@en
The World Federation of Societ ...... , Part II: Treatment of Mania.
@nl
prefLabel
The World Federation of Societ ...... , Part II: Treatment of Mania.
@ast
The World Federation of Societ ...... , Part II: Treatment of Mania.
@en
The World Federation of Societ ...... , Part II: Treatment of Mania.
@nl
P2093
P2860
P50
P1476
The World Federation of Societ ...... , Part II: Treatment of Mania.
@en
P2093
Charles Bowden
David Baldwin
Guy Goodwin
Heinz Grunze
Rasmus W Licht
WFSBP Task Force on Treatment Guidelines for Bipolar Disorders
P2860
P356
10.3109/15622970309167904
P577
2003-01-01T00:00:00Z